GETI.B

221.4

+0.82%↑

CAMX

581

-1.44%↓

VITR

166

+2.91%↑

BIOAB

190.5

+4.61%↑

ARJOB

36.62

-0.7%↓

GETI.B

221.4

+0.82%↑

CAMX

581

-1.44%↓

VITR

166

+2.91%↑

BIOAB

190.5

+4.61%↑

ARJOB

36.62

-0.7%↓

GETI.B

221.4

+0.82%↑

CAMX

581

-1.44%↓

VITR

166

+2.91%↑

BIOAB

190.5

+4.61%↑

ARJOB

36.62

-0.7%↓

GETI.B

221.4

+0.82%↑

CAMX

581

-1.44%↓

VITR

166

+2.91%↑

BIOAB

190.5

+4.61%↑

ARJOB

36.62

-0.7%↓

GETI.B

221.4

+0.82%↑

CAMX

581

-1.44%↓

VITR

166

+2.91%↑

BIOAB

190.5

+4.61%↑

ARJOB

36.62

-0.7%↓

Search

Elekta AB

Closed

54 -0.55

Overview

Share price change

24h

Current

Min

54

Max

54.15

Key metrics

By Trading Economics

Income

156M

431M

Sales

354M

4.7B

P/E

Sector Avg

20.754

73.239

EPS

0.94

Dividend yield

4.25

Profit margin

9.18

Employees

4,541

EBITDA

152M

849M

Dividends

By Dow Jones

Dividend yield

Sector Avg

4.25%

3.06%

Market Stats

By TradingEconomics

Market Cap

-2.1B

21B

Previous open

54.55

Previous close

54

Elekta AB Chart

Past performance is not a reliable indicator of future results.

Related News

30 Mar 2025, 23:43 UTC

Market Talk

Gold Edges Higher, Supported by Looming U.S. Tariffs -- Market Talk

30 Mar 2025, 23:41 UTC

Market Talk

Global Equities Roundup: Market Talk

30 Mar 2025, 23:41 UTC

Market Talk

Nikkei May Fall Amid Concerns About U.S. Tariffs, Borrowing Costs -- Market Talk

30 Mar 2025, 23:12 UTC

Earnings

Tsingtao Brewery 2024 Net CNY4.34B Vs. Net CNY4.27B >0168.HK

30 Mar 2025, 23:12 UTC

Earnings

Tsingtao Brewery Board Proposes Final Dividend of CNY2.20/Share >0168.HK

30 Mar 2025, 23:12 UTC

Earnings

Tsingtao Brewery 2024 Rev CNY32.14B Vs. CNY33.94B >0168.HK

30 Mar 2025, 22:30 UTC

Earnings

Great Wall Motor 2024 Net CNY12.69 Vs. Net CNY7.02B >2333.HK

30 Mar 2025, 22:30 UTC

Earnings

Great Wall Motor: Higher Overseas Vehicle Sales Among Factors Supporting Results >2333.HK

30 Mar 2025, 22:30 UTC

Earnings

Great Wall Motor 2024 Rev CNY202.20B Vs. CNY173.21B >2333.HK

30 Mar 2025, 21:44 UTC

Market Talk

Barclays Favors Core Bonds Over Equities as Tariffs Loom -- Market Talk

30 Mar 2025, 21:24 UTC

Market Talk

Early Polling Shows Labor's Support Firms Before Australia Vote -- Market Talk

30 Mar 2025, 21:23 UTC

Top News

Trump Team Weighs Broader, Higher Tariffs -- WSJ

30 Mar 2025, 16:23 UTC

Top News

Tesla's EV Credit Income Is Still Rolling In -- for Now -- Barrons.com

30 Mar 2025, 09:30 UTC

Top News

The AI Data-Center Boom Is Coming to America's Heartland -- WSJ

30 Mar 2025, 09:30 UTC

Top News

Tariffs on Screws Are Already Hitting Manufacturers -- WSJ

29 Mar 2025, 13:00 UTC

Top News

Trump's Trade War Arrives in America's Heartland -- WSJ

29 Mar 2025, 11:00 UTC

Top News

Selling Your House This Spring? You Might Need to Cut the Price -- Heard on the Street -- WSJ

29 Mar 2025, 09:30 UTC

Top News

The Auto Union Boss Who Went From Trump Foe to Tariff Cheerleader -- WSJ

29 Mar 2025, 08:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

29 Mar 2025, 08:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

29 Mar 2025, 00:00 UTC

Top News

The Drone-Delivery Service Beating Amazon to Your Front Door -- WSJ

28 Mar 2025, 23:16 UTC

Acquisitions, Mergers, Takeovers

CoreWeave Debuts: A Big IPO in a Slow Year -- Barrons.com

28 Mar 2025, 22:21 UTC

Top News

Inflation, Consumer Fears Fuel Stock Selloff -- WSJ

28 Mar 2025, 21:49 UTC

Top News

FCC Investigates Disney for DEI Practices, Chair Says -- 2nd Update

28 Mar 2025, 21:28 UTC

Top News

Stocks Fall on Tariff, Consumer Sentiment Fears -- WSJ

28 Mar 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

28 Mar 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

28 Mar 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

28 Mar 2025, 20:40 UTC

Top News

OpenAI's Latest Funding Round Comes With a $20 Billion Catch -- WSJ

28 Mar 2025, 20:36 UTC

Top News

Consumers' Mood Sours in March With Gloomier Economic Outlook -- 4th Update

Peer Comparison

Price change

Elekta AB Forecast

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Elekta AB

Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit; Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Leksell GammaPlan, a treatment planning and management software. In addition, the company offers Elekta ONE, a software suite of multiple Elekta solutions. Further, it provides brachytherapy products, including Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Elekta Xoft Axxent, and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Additionally, the company offers neurosurgery products, such as Leksell Vantage Stereotactic System for intracranial neurosurgery. Furthermore, it provides Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.